In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.
about
Ceftriaxone disposition in open-heart surgery patients.BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.Pharmacokinetics of ceftriaxone in humans.In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.Efficacy of ceftriaxone in serious bacterial infections.Ceftriaxone: in vitro studies and clinical evaluationIn vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteersComparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.In vitro activity of cefodizime.Use of third-generation cephalosporins. Pseudomonas.Use of third-generation cephalosporins. Enterobacteriaceae.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.Unusual mode of inhibition of Citrobacter freundii beta-lactamases by ceftriaxone.A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic.Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
P2860
Q33742082-C40E3A99-05B1-44DF-9A32-208425B1A9F8Q35670880-970F1679-736A-44E5-BC65-8EEB37679FBFQ35672073-D2085DD5-7920-45B2-9A6E-16C7E1167C1CQ35672612-4F1ED196-54D2-43B0-A2BE-46A9613A68E3Q35672864-78F681DF-EAAC-41B2-A215-29C4E504EDC9Q35674264-1FDC5274-6415-4E8B-ACAF-0992132116DBQ35712352-08C2C7C8-750E-4892-B10C-1B53D776B453Q35760623-FF4438A1-DDCA-4A26-BBA9-1FAE64928CFEQ35767452-684A20C8-8D66-425C-9886-620CD772BCB5Q35769451-6CD44186-8ACE-4A5A-9FCF-DFD0053BE173Q35842207-4CF8BBB4-D716-4E39-A645-E321347523B3Q37381368-2EFB17C8-6595-40EE-B72F-FB9E7E06285FQ37381380-20B71EFD-F4B5-46AD-8AA9-464F0AD63FE6Q39835731-2EB75AC1-4201-41EC-A167-5727BB544E5AQ39854506-4844AFAA-BA8A-4ED4-8B2E-C1989250BD0AQ39855525-31257A0E-83BB-4D50-AC1F-13859A782093Q39855537-A5E47367-CBA2-49AF-B83C-E2545856FE76Q41849834-06FF1B5A-A6A0-40AB-957B-9C235E283CE8Q41933130-45E399FC-E440-49E5-AD7D-7A5F4DD7E63DQ42176930-4EF743A9-F7BB-47E3-BE95-6C2434C40602Q42929968-ACF74E35-0E7D-4041-852D-BF2436674101Q54513149-2BE7560A-7A84-4C30-B946-A2FE97294CE7
P2860
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
In vitro antibacterial activit ...... Ro 13-9904 to beta-lactamases.
@en
type
label
In vitro antibacterial activit ...... Ro 13-9904 to beta-lactamases.
@en
prefLabel
In vitro antibacterial activit ...... Ro 13-9904 to beta-lactamases.
@en
P2093
P356
P1476
In vitro antibacterial activit ...... Ro 13-9904 to beta-lactamases.
@en
P2093
P304
P356
10.1128/AAC.18.2.292
P407
P577
1980-08-01T00:00:00Z